AstraZeneca Covid-19 Vaccine’s Benefits Outweigh Risks, Says EU


The European Union’s health authority said it is still firmly convinced that the benefits of AstraZeneca PLC’s Covid-19 vaccine outweigh the risks, after a string of nations in the bloc temporarily halted use of the shot over blood-clot concerns.

The European Medicines Agency so far sees no indication that the vaccine caused a number of blood-clotting incidents reported across the region, Executive Director Emer Cooke said in a briefing Tuesday.

The EU’s health agency is currently reviewing those incidents to determine whether they represent a broader risk. Ms. Cooke said the results of the review would be presented Thursday.

She said that blood-clot incidents remain very rare, while thousands of people continue to die from conditions related to Covid-19.

“Trust in the safety and efficacy of the vaccines…is paramount for us,” Ms. Cooke said. “We are worried there may be an effect on the trust of the vaccines.”

Source link


Please enter your comment!
Please enter your name here